XML 86 R74.htm IDEA: XBRL DOCUMENT v3.22.2.2
Investments in and Advances to Joint Ventures - Summary of Financial Information for Unconsolidated Joint Ventures (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Schedule Of Equity Method Investments [Line Items]          
Current assets $ 1,610,798   $ 1,610,798   $ 1,632,351
Total assets 4,094,990   4,094,990   3,830,940
Current liabilities 1,149,479   1,149,479   1,030,784
Total liabilities 2,089,898   2,089,898   1,893,828
Total joint venture equity 1,953,066   1,953,066   1,900,768
Investments in and advances to unconsolidated joint ventures 99,424   99,424   110,688
Revenue 1,134,370 $ 956,050 3,092,160 $ 2,710,103  
Costs 872,423 734,652 2,388,095 2,084,062  
Net income attributable to Parsons Corporation 29,571 19,358 68,533 35,099  
Equity in earnings of unconsolidated joint ventures (974) 9,570 10,237 26,528  
Unconsolidated Joint Ventures          
Schedule Of Equity Method Investments [Line Items]          
Current assets 1,770,762   1,770,762   1,620,735
Noncurrent assets 487,823   487,823   531,261
Total assets 2,258,585   2,258,585   2,151,996
Current liabilities 1,357,131   1,357,131   1,088,985
Noncurrent liabilities 467,030   467,030   669,911
Total liabilities 1,824,161   1,824,161   1,758,896
Total joint venture equity 434,424   434,424   393,100
Investments in and advances to unconsolidated joint ventures 99,424   99,424   $ 110,688
Revenue 782,880 728,461 1,762,420 1,701,262  
Costs 774,030 697,493 1,711,555 1,604,538  
Net income attributable to Parsons Corporation $ 8,850 $ 30,968 $ 50,865 $ 96,724